1. Zelinskaja D.I., Terleckaja R.N. Disability of the children’s population of Russia (modern legal and medical-social processes). Monograph. M.: Jurajt; 2019: 194. (in Russ.)
2. Novikov P.V. The problem of rare (orphan) diseases in the Russian Federation: medical and normative legal aspects of its solution. Terapevticheskii arkhiv 2014; 86(12–2): 3–12. (in Russ.)
3. Berry S.A., Coughlin C.R., McCandless S., McCarter R., Seminara J., Yudkoff M., LeMons C. Developing interactions with industry in rare diseases: lessons learned and continuing challenges. Genet Med 2020; 22(1): 219–226. DOI: 10.1038/s41436-019-0616-9
4. Brenna E., Polistena B., Spandonaro F. The implementation of health technology assessment principles in public decisions concerning orphan drugs. Eur J Clin Pharmacol 2020; 22(1): 219–226. DOI: 10.1007/s00228-020-2855-7
5. Mihajlenko E.V., Kuz’min S.B. Analysis of the legal regulation of drug supply of citizens of the Russian Federation suffering from orphan diseases. Meditsinskoe pravo: teoriya i praktika 2018; 4(7): 226–230. (in Russ.)